Development 

An ophthalmic formulation with enhanced penetration,  potent anti-inflammatory activity and reduced dosing frequency for the treatment of inflammation and pain post ocular surgery under the regulatory 505(b)(2) pathway.

Research 

• Discovery and early development of novel or improved antibiotics against resistant bacteria and other microorganisms.